Increased Risk of CKD among Type 2 Diabetics with... : Journal of the American Society of Nephrology (original) (raw)

CLINICAL EPIDEMIOLOGY

Increased Risk of CKD among Type 2 Diabetics with Nonalcoholic Fatty Liver Disease

Targher, Giovanni*, †; Chonchol, Michel‡; Bertolini, Lorenzo†; Rodella, Stefano§; Zenari, Luciano†; Lippi, Giuseppe‖; Franchini, Massimo¶; Zoppini, Giacomo*; Muggeo, Michele*

*Section of Endocrinology, Department of Biomedical and Surgical Sciences, and ‖Section of Clinical Chemistry, Department of Biomedical and Morphological Sciences, University of Verona, and ¶Service of Immuno-hematology and Transfusion, Civil Hospital, Verona, †Department of Internal Medicine and Diabetes Unit and §Department of Radiology, “Sacro Cuore” Hospital, Negrar, Italy; and ‡Division of Renal Diseases and Hypertension, University of Colorado Health Sciences Center, Denver, Colorado

Correspondence: Dr. Giovanni Targher, Section of Endocrinology, Department of Biomedical and Surgical Sciences, University of Verona, Ospedale Civile Maggiore, Piazzale Stefani, 1, 37126 Verona, Italy. Phone: 0039-045-8123748; Fax: 0039-045-917374; E-mail: [email protected]

Accepted February 11, 2008

Received October 30, 2007

Abstract

It is unknown whether chronic kidney disease (CKD) is associated with nonalcoholic fatty liver disease among patients with type 2 diabetes. We followed 1760 outpatients with type 2 diabetes and normal or near-normal kidney function and without overt proteinuria for 6.5 yr for the occurrence of CKD (defined as overt proteinuria and/or estimated GFR <60 ml/min per 1.73 m2). During follow-up, 547 participants developed incident CKD. Nonalcoholic fatty liver disease, diagnosed by liver ultrasound and exclusion of other common causes of chronic liver disease, was associated with a moderately increased risk for CKD (hazard ratio 1.69; 95% confidence interval 1.3 to 2.6; P < 0.001). Adjustments for gender, age, body mass index, waist circumference, BP, smoking, diabetes duration, glycosylated hemoglobin, lipids, baseline estimated GFR, microalbuminuria, and medications (hypoglycemic, lipid-lowering, antihypertensive, or antiplatelet drugs) did not appreciably attenuate this association (hazard ratio 1.49; 95% confidence interval 1.1 to 2.2; P < 0.01). In conclusion, our findings suggest that nonalcoholic fatty liver disease is associated with an increased incidence of CKD in individuals with type 2 diabetes, independent of numerous baseline confounding factors.